Concortis Biosystems' Acquisition

Concortis Biosystems was acquired by Sorrento Therapeutics on December 20, 2013.

Concortis is a biotechnology company creating next generation biotherapeutics using its conjugation technologies and novel drug delivery systems, which allow the company to build small molecule drugs …

Articles about Concortis Biosystems' Acquisition: